Table 4. Anti S9/P2 and anti BDC2.5 TscFv IgG in serum of BDC2.5 TCR tg recipients after transfer of B-cells from donors vaccinated with TscFv S9/P2 or BDC2.5.
Parameter [units] | Donor vaccination* | Day 22 | Day 36 | Day 50 |
anti BDC2.5 IgG [AU] | BDC2.5 | 76±20 | 81±53 | 77±25 |
anti S9/P2 IgG [AU] | S9/P2 | 55±23 | 77±56 | 99±23 |
BDC2.5 TCR tg mice without transfer of B-cells from S9/P2 or BDC2.5-vaccinated donors have no detectable serum levels of anti S9/P2 or anti BDC2.5 IgG.